MTA3 and breast cancer: With BC progression, GATA3, G9aand MTA3 are down-regulated and ZEB2 is up-regulated.This upregulation, in turn contributes to the decrease inthe expression levels of G9a and MTA3 via the G9a/NURD (MTA1) complex (27).